Pfizer Inc (PFE) Stock Price, Quote & News

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General

Sector: Healthcare

Phone: 212 733 2323

Website: www.pfizer.com

Address:

66 Hudson Boulevard East, New York, United States

JBS_84 Jun. 16 at 8:09 PM

$PFE Simply crawling along at the bottom of the channel. Very well respected. Might take a bit to break out but when it does get out in the 29's and reenter in the 26's. Of course when it gets to the 29's everyone will be going on about hitting 35 or something stupid. Thats the hint to sale. Just like now with the people thinking its going to 24. Nope. This is the buy zone.

1 · Reply

Micheal_Pothead Jun. 16 at 8:01 PM

$PFE 26.13 was poison today

0 · Reply

TeamSetupAlpha Jun. 16 at 7:40 PM

What a gorgeous 1-day print on $SPCU. +$3,835.36 secured. But greed kills accounts. Time to ring the register. 220 shares up nearly 35% in hours. Total value sitting at $10.7K. Never let a massive intraday equity winner round-trip. When a stock goes vertical, move your stops to breakeven and trim 50% immediately. Capital preservation > ego. Lock in the realized gains and reset for tomorrow. $SPCU $BLK $PLD $PFE $SNAP

0 · Reply

Find_the_Cure Jun. 16 at 7:36 PM

$PFE 😝

0 · Reply

Lord_Burglekutt Jun. 16 at 7:10 PM

$COSM It's pump time. After hours gonna be filthy. $SPY $NVDA $TSLA $PFE

0 · Reply

Micheal_Pothead Jun. 16 at 7:06 PM

$PFE this is genuinely comical

0 · Reply

MrPeanutEsquire Jun. 16 at 7:03 PM

$PFE If you want to loose hardly any money at all. This is the best stock to ever do it. It will consistently loose you almost nothing. Youll barley even feel it

0 · Reply

Micheal_Pothead Jun. 16 at 6:04 PM

$PFE genuinely can’t hold gains to save its life

0 · Reply

NorthOfSouth Jun. 16 at 5:11 PM

$PFE If Al would just wear that maga cap...even for 1 day... Boom I tell ya BOOM.

0 · Reply

UltraInstinct Jun. 16 at 4:58 PM

$MRNA It’s insane how this has no correlation with $PFE

0 · Reply

Pfizer CEO warns German investment at risk over drug pricing policies

2026-06-09T21:05:52.000Z - 7 days ago

Pfizer upgraded to Sector Perform from Underperform at RBC Capital

2026-06-09T21:05:12.000Z - 7 days ago

Pfizer upgraded to Sector Perform at RBC Capital amid more balanced risk-reward

Jun 9, 2026, 2:07 PM EDT - 7 days ago

Want to Avoid the Whipsawing Tech Stocks? Dollar General and 7 Others to Buy.

DG ALGN BBY BIIB CVS VZ

Jun 9, 2026, 9:20 AM EDT - 7 days ago

Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying

AMGN JNJ LLY MRK NVO

Jun 9, 2026, 3:20 AM EDT - 7 days ago

The space race is coming for pharma: Why drug development is heading to lower Earth orbit

BMY LLY MRK RDW UTHR XBI

Jun 8, 2026, 8:00 AM EDT - 8 days ago

Pfizer Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

2026-06-08T10:51:57.000Z - 8 days ago

Pfizer says FDA approves expanded indication for Hympavzi

Jun 8, 2026, 6:49 AM EDT - 8 days ago

US FDA approves Pfizer's bleeding disorder drug for children

Jun 8, 2026, 6:45 AM EDT - 8 days ago

U.S. FDA Approves Pfizer's HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need

2026-06-07T22:00:49.000Z - 8 days ago

Pfizer presents results from Phase 2b studies of berobenatide

Jun 6, 2026, 11:00 AM EDT - 10 days ago

Pfizer Transcript: Study update

Jun 6, 2026, 11:00 AM EDT - 10 days ago

Pfizer Slides: Study update

Jun 6, 2026, 9:06 AM EDT - 10 days ago

Pfizer's monthly obesity shot has side-effect profile similar to Wegovy in midstage trial

Jun 6, 2026, 9:00 AM EDT - 10 days ago

Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer's GLP-1 RA Berobenatide

Jun 4, 2026, 10:00 AM EDT - 12 days ago

Chai Discovery Announces License Agreement with Pfizer to Accelerate Drug Discovery with AI

Jun 4, 2026, 6:40 AM EDT - 12 days ago

Why Pfizer And Eli Lilly Are Betting On This $1.3 Billion AI Drug Discovery Startup

LLY

Jun 3, 2026, 2:00 PM EDT - 13 days ago

Pfizer Transcript: Jefferies Global Healthcare Conference 2026

Jun 1, 2026, 10:00 AM EDT - 15 days ago

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

2026-05-31T13:45:07.000Z - 16 days ago

Pfizer announces results from Cohort 3 on Bratovi with cetuximab, Folfiri

2026-05-31T13:25:52.000Z - 16 days ago

Pfizer announces results from Phase 3 Talapro-3 study of Talzenna, Xtandi

May 31, 2026, 8:00 AM EDT - 16 days ago

Pfizer's BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer

May 30, 2026, 9:22 AM EDT - 17 days ago

Mailbag: A Follow-Up on Pfizer & Other Questions

AGNC LAND NLY PFFA

May 30, 2026, 8:00 AM EDT - 17 days ago

TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer

2026-05-29T13:17:15.000Z - 18 days ago

Pfizer announces seven-year follow-up results from Phase 3 CROWN trial

May 29, 2026, 8:00 AM EDT - 18 days ago

Seven-Year Analysis from Pfizer's LORBRENA CROWN Trial Shows Longest Progression-Free Survival Reported to Date in Advanced Non-Small Cell Lung Cancer

May 28, 2026, 11:10 PM EDT - 18 days ago

Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion

May 28, 2026, 7:19 PM EDT - 18 days ago

China's Innovent Biologics, Pfizer strike up to $10.5 billion cancer drug deal

2026-05-28T23:05:16.000Z - 18 days ago

Pfizer enters into global strategic collaboration with Innovent Biologics

May 28, 2026, 7:00 PM EDT - 18 days ago

Innovent Biologics and Pfizer Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

May 28, 2026, 7:00 PM EDT - 18 days ago

Pfizer and Innovent Biologics Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

2026-05-28T12:35:12.000Z - 19 days ago

Guardant Health to present 38 abstracts at ASCO 2026 meeting

May 27, 2026, 10:00 AM EDT - 20 days ago

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

May 20, 2026, 9:00 AM EDT - 27 days ago

Sarah Cannon Research Institute Announces Strategic Oncology Research Collaboration with Pfizer

May 20, 2026, 5:08 AM EDT - 27 days ago

Pfizer's pneumococcal shot shows stronger immune response in mid-stage trial

May 20, 2026, 5:05 AM EDT - 27 days ago

Pfizer Advances Pivotal Pediatric Pneumococcal Vaccine Program Following Strong Positive Phase 2 Results

May 18, 2026, 8:00 AM EDT - 4 weeks ago

Astellas to Present Data on Long-Term Outcomes and Clinical Use of Its Portfolio Across Disease Stages at ASCO 2026

May 14, 2026, 2:22 PM EDT - 4 weeks ago

Quest Diagnostics, Altria, and 12 More Stocks That Are Coming Back to Life After a Rough Patch

DGX MO CL

May 13, 2026, 6:45 AM EDT - 4 weeks ago

European Commission Approves Pfizer's HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors

May 12, 2026, 8:00 AM EDT - 5 weeks ago

Rigel strikes licensing deal for Pfizer and Arvinas' breast cancer drug

ARVN RIGL

May 12, 2026, 7:00 AM EDT - 5 weeks ago

Arvinas and Pfizer Enter into a Transaction with Rigel Pharmaceuticals for the Exclusive Global Rights of VEPPANU (vepdegestrant)

ARVN

May 5, 2026, 4:09 PM EDT - 6 weeks ago

Pfizer CEO on Drug Pipeline, Trump's Pick to Lead CDC

May 5, 2026, 4:02 PM EDT - 6 weeks ago

Pfizer CEO on AI-designed molecule, and race to use new tech

May 5, 2026, 11:30 AM EDT - 6 weeks ago

3 Dividend Stocks for May 2026

SYY WSO

May 5, 2026, 10:00 AM EDT - 6 weeks ago

Pfizer Earnings Call Transcript: Q1 2026

May 5, 2026, 10:00 AM EDT - 6 weeks ago

Pfizer Earnings release: Q1 2026

May 5, 2026, 10:00 AM EDT - 6 weeks ago

Pfizer Quarterly report: Q1 2026

May 5, 2026, 10:00 AM EDT - 6 weeks ago

Pfizer Slides: Q1 2026

May 5, 2026, 8:35 AM EDT - 6 weeks ago

Pfizer Posts Better-Than-Expected Revenue, Profit

May 5, 2026, 7:23 AM EDT - 6 weeks ago

Pfizer Revenue Rises But Profit Falls Amid Boosted R&D Spending

May 5, 2026, 7:06 AM EDT - 6 weeks ago

Pfizer Stock Edges Higher as Earnings and Revenue Beat Estimates

May 5, 2026, 7:05 AM EDT - 6 weeks ago

Why selling these 3 dividend stocks could be a mistake

EPD UPS

May 5, 2026, 6:55 AM EDT - 6 weeks ago

Pfizer tops Wall Street estimates, reaffirms outlook as newer products show growth

May 5, 2026, 6:51 AM EDT - 6 weeks ago

Pfizer beats first-quarter profit estimates on strong demand for blood thinner Eliquis

May 5, 2026, 6:45 AM EDT - 6 weeks ago

Pfizer Reports Strong First-Quarter Results And Reaffirms 2026 Guidance

May 1, 2026, 12:37 PM EDT - 6 weeks ago

US FDA approves Pfizer, Arvinas' breast cancer drug

ARVN

Apr 29, 2026, 7:42 AM EDT - 6 weeks ago

Pfizer's blood cancer drug meets main goal in late-stage trial

$Pfizer's ELREXFIO Significantly Improves Progression-Free Survival for Double-Class Exposed Patients with Relapsed or Refractory Multiple Myeloma$

Apr 29, 2026, 6:45 AM EDT - 6 weeks ago

Pfizer's ELREXFIO Significantly Improves Progression-Free Survival for Double-Class Exposed Patients with Relapsed or Refractory Multiple Myeloma

Apr 28, 2026, 10:41 AM EDT - 7 weeks ago

Pfizer secures deals to keep heart drug free of generic rivals until 2031

Apr 28, 2026, 10:17 AM EDT - 7 weeks ago

Pfizer Reaches Three Settlement Agreements for VYNDAMAX

Apr 24, 2026, 8:36 AM EDT - 7 weeks ago

Bristol Myers, Pfizer to offer blockbuster blood thinner through Mark Cuban's online pharmacy

BMY

Apr 23, 2026, 9:00 AM EDT - 7 weeks ago

Pfizer Transcript: AGM 2026

Apr 22, 2026, 4:45 PM EDT - 7 weeks ago

Pfizer Declares Second-Quarter 2026 Dividend

Apr 22, 2026, 5:18 AM EDT - 7 weeks ago

Pfizer GLP-1 weight loss drug available for pre-order in China

Apr 21, 2026, 11:51 AM EDT - 2 months ago

Pfizer Showcases Oncology Innovation and Next-Generation Pipeline at ASCO 2026

Apr 20, 2026, 3:05 PM EDT - 2 months ago

Pfizer's Strategy and Innovation Officer Andrew Baum to leave drugmaker, analyst note says

Apr 20, 2026, 6:45 AM EDT - 2 months ago

U.S. FDA Grants Priority Review to sBLA for PADCEV™ + Keytruda® as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

Apr 16, 2026, 1:01 PM EDT - 2 months ago

The Big 3: PFE, V, SYF

SYF V

JBS_84 Jun. 16 at 8:09 PM

1 · Reply

Micheal_Pothead Jun. 16 at 8:01 PM

$PFE 26.13 was poison today

0 · Reply

TeamSetupAlpha Jun. 16 at 7:40 PM

0 · Reply

Find_the_Cure Jun. 16 at 7:36 PM

$PFE 😝

0 · Reply

Lord_Burglekutt Jun. 16 at 7:10 PM

$COSM It's pump time. After hours gonna be filthy. $SPY $NVDA $TSLA $PFE

0 · Reply

Micheal_Pothead Jun. 16 at 7:06 PM

$PFE this is genuinely comical

0 · Reply

MrPeanutEsquire Jun. 16 at 7:03 PM

$PFE If you want to loose hardly any money at all. This is the best stock to ever do it. It will consistently loose you almost nothing. Youll barley even feel it

0 · Reply

Micheal_Pothead Jun. 16 at 6:04 PM

$PFE genuinely can’t hold gains to save its life

0 · Reply

NorthOfSouth Jun. 16 at 5:11 PM

$PFE If Al would just wear that maga cap...even for 1 day... Boom I tell ya BOOM.

0 · Reply

UltraInstinct Jun. 16 at 4:58 PM

$MRNA It’s insane how this has no correlation with $PFE

0 · Reply

Micheal_Pothead Jun. 16 at 4:39 PM

$PFE random 2-3% straight up candle tomorrow at 9:30 on absolutely no news whatsoever incoming

2 · Reply

TraderDaKing Jun. 16 at 4:13 PM

$PFE $SPCX

0 · Reply

MRTunity Jun. 16 at 4:06 PM

$SLS This months MAIN EVENT Wrestlemania Style… in the biotech sphere 🧬 💪 Tag team Championship belt on the line for GPS+SLS009… We got in one corner $RHHBY &amp; $ABBV In the other corner team of $MRK &amp; $PFE Who you places your bets on Longs ⁉️ Mine is on SELLAS LIFE SCIENCES + Angelos 👊🏼

2 · Reply

cb5000calls Jun. 16 at 2:38 PM

$SLS @FlockOfSeagulls you are being awfully quiet right now after making your joint buyout prediction.... well where is it??? Funny timing with @love_to_learn account being banned/wiped right after he disclosed/alluded to $PFE connection with buyout.

2 · Reply

OmarKingW Jun. 16 at 2:25 PM

$IBRX $PFE Wrong chat MUTED HIM

0 · Reply

WantedToRetireEarly Jun. 16 at 2:11 PM

$IBRX this drug is showing real efficacy in tbe fight against NSCL cancer. Made by $PFE Lorlatinib is a third-generation ALK (anaplastic lymphoma kinase) inhibitor used to treat non-small cell lung cancer (NSCLC) in patients whose tumors have an ALK gene mutation or rearrangement. It works by blocking the ALK protein that drives cancer cell growth, and is notable for its ability to cross the blood-brain barrier, making it effective against brain metastase https://x.com/cremieuxrecueil/status/2060955532559581294?s=46&t=jKXapJZhCmbNduU3W_BgJQ

1 · Reply

MrPeanutEsquire Jun. 16 at 2:01 PM

$PFE glad im waiting with the dividend. Always gets cheaper...

1 · Reply